clinical use of endosonography (eus)
TRANSCRIPT
![Page 1: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/1.jpg)
Clinical use of endosonography
(EUS)(EUS)
![Page 2: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/2.jpg)
EUS equipment
• What types of echoendoscopes (EUS) are used
in clinical practice?
![Page 3: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/3.jpg)
EUS equipment
• What types of echoendoscopes (EUS) are used
in clinical practice?
– Radial EUS (mechanical and electronically 5-10-20 – Radial EUS (mechanical and electronically 5-10-20
MHz)
– Liniar EUS (5-7.5 MHz)
– Mini-probe EUS (high frequency, 20MHz)
![Page 4: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/4.jpg)
Indications EUS
• What are indications for EUS?
![Page 5: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/5.jpg)
Indications EUS
• What are indications for EUS?
– Evaluation of luminal malignancies
– Evaluation of submucosal abnormalities
– Evaluation of pancreatico-biliary disease
– Evaluation of mediastinal disease
– Evaluation of perianal disease
– Evaluation of extraluminal lesions identified by other modalities
– Therapeutic applications
![Page 6: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/6.jpg)
Esophageal EUS
• What is the role of EUS in Barrett esophagus?
– No dysplasie / low grade dysplasia
– High-grade dysplasia
![Page 7: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/7.jpg)
Esophageal EUS
• What is the role of EUS in Barrett esophagus?
– No dysplasie / low grade dysplasia
– High-grade dysplasia
– No indication for EUS in low-grade / no dysplasia
– Exclude deep invasion / submucosal invasion
– Exclude loco-regional lymphadenopathie
![Page 8: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/8.jpg)
Esophageal EUS
• What is the role of EUS in staging of
esophageal cancer?
![Page 9: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/9.jpg)
Esophageal EUS
• What is the role of EUS in staging of
esophageal cancer?
– EUS is superior to CT in local (T) staging– EUS is superior to CT in local (T) staging
– Nodal involvement at least as good as CT
– Limited role for distant metastases (ev. liver
metastases)
![Page 10: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/10.jpg)
Gastric EUS
• What is the accuracy of EUS in staging of
gastric cancer?
![Page 11: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/11.jpg)
Gastric EUS
• What is the accuracy of EUS in staging of
gastric cancer?
– T stage: 71-88% (superior to CT)– T stage: 71-88% (superior to CT)
– N stage: 77-80% (superior to CT)
– Risk of overstaging (particular T2)
![Page 12: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/12.jpg)
Gastric EUS
• What is the accuracy of EUS in staging of
gastric lymphoma?
![Page 13: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/13.jpg)
Gastric EUS
• What is the accuracy of EUS in staging of
gastric lymphoma?
– T stage: 91-95%– T stage: 91-95%
– N stage: 77-83%
![Page 14: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/14.jpg)
EUS submucosal lesions
• Correlate EUS pattern with most likely
pathology
Anechoic LeiomyomaAnechoic Leiomyoma
Hyperechoic GIST
Hypoechoic Lipoma
Liposarcoma
Cystic lesion
![Page 15: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/15.jpg)
EUS submucosal lesions
• Correlate EUS pattern with most likely
pathology
Anechoic LeiomyomaAnechoic Leiomyoma
Hyperechoic GIST
Hypoechoic Lipoma
Liposarcoma
Cystic lesion
![Page 16: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/16.jpg)
EUS submucosal lesions
• How high is the match between EUS patterns
of submucosal lesions and pathology?
• What is the accuracy of EUS with FNA to diagnose
submucosal lesions?submucosal lesions?
![Page 17: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/17.jpg)
EUS submucosal lesions
• How high is the match between EUS patterns
of submucosal lesions and pathology?
• What is the accuracy of EUS with FNA to diagnose
submucosal lesions?submucosal lesions?
• EUS matches pathology: 77%
• EUS + FNA accuracy: 80-92%
![Page 18: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/18.jpg)
EUS submucosal lesions
• Which markers ar diagnostic for GIST tumors?
– C-Kit (CD 117)
– Desmin
– S-100–
– Actin
– CD34
![Page 19: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/19.jpg)
EUS submucosal lesions
• Which markers ar diagnostic for GIST tumors?
– C-Kit (CD 117)
– Desmin
– S-100–
– Actin
– CD34
![Page 20: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/20.jpg)
EUS pancreatic lesion
• What is the differential diagnosis of pancreatic
tumors?
![Page 21: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/21.jpg)
EUS pancreatic lesion
• What is the differential diagnosis of pancreatic
tumors?
– Adenocarcinoma
– Lymphoma– Lymphoma
– Neuroendocrine Tumors (NET)
![Page 22: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/22.jpg)
EUS pancreatic lesion
• EUS is superior to CT and/or MRI in identifying
pancreatic lesions?
True/False
• EUS is superior to CT/MRI in staging pancreatic
cancer?
True/False
![Page 23: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/23.jpg)
EUS pancreatic lesion
• EUS is superior to CT and/or MRI in identifying
pancreatic lesions?
True/False
• EUS is superior to CT/MRI in staging pancreatic
cancer?
True/False
![Page 24: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/24.jpg)
EUS pancreatic lesion
• Which conditions limit the ability of EUS to
identify pancreatic cancers?
![Page 25: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/25.jpg)
EUS pancreatic lesion
• Which conditions limit the ability of EUS to
identify pancreatic cancers?
– Chronic pancreatitis– Chronic pancreatitis
– Diffuse infiltrative pancreatic cancer
– Proeminent ventral/dorsal anlage
– Acute pancreatitis
![Page 26: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/26.jpg)
EUS choledocholithiasis
• What is the accuracy of EUS to detect
choledocholithiasis?
– EUS vs. Transabdominal US
– EUS vs. MRI/MRCP– EUS vs. MRI/MRCP
– EUS vs. ERCP
![Page 27: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/27.jpg)
EUS choledocholithiasis
• What is the accuracy of EUS to detect
choledocholithiasis?
– EUS >> Transabdominal US
– EUS = MRI/MRCP– EUS = MRI/MRCP
– EUS < ERCP (but more cost-effective than Dx ERCP)
– Accuracy EUS for choledocholithiasis >90%
![Page 28: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/28.jpg)
EUS choledocholithiasis
• Which are very strong, strong and moderate
predictors for choledocholithiasis?
![Page 29: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/29.jpg)
EUS choledocholithiasis
• Which are very strong, strong and moderate predictorsfor choledocholithiasis?– Very strong:
• CBD stones on transabdominal US
• Clincal ascending cholangitis
• Bilirubin >4mg/dl (>68 mcmol/L)• Bilirubin >4mg/dl (>68 mcmol/L)
– Strong:• Dilated CBD >6mm with gallbladder in situ
• Bilirubin 1.8 – 4.0 mg/dL (30-68 mcmol/L)
– Moderate• Abnormal LFT‘s other than bilirubin
• Clinically gallstone pancreatitis
• Age >55years
![Page 30: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/30.jpg)
EUS choledocholithiasis
• What are the criteria to high, intermediate
and low probability of CBD stones?
![Page 31: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/31.jpg)
EUS choledocholithiasis
• What are the criteria to high, intermediate
and low probability of CBD stones?
– High probability:
• Any very strong perdictor• Any very strong perdictor
• Both strong predictors (CBD >6mm and Bilirubin 30-68)
– Low probability
• No predictors
– Intermediate probability
• One strong predictor and any moderate predictors
![Page 32: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/32.jpg)
EUS choledocholithiasis
• What is the role of EUS in suspected
choledocholitiasis?
![Page 33: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/33.jpg)
Complications of EUS
• What is the perforation rate for diagnostic
EUS?
– How does it compare to the perforation rate of
gastroscopy?gastroscopy?
![Page 34: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/34.jpg)
Complications of EUS
• What is the perforation rate for diagnostic
EUS?
– How does it compare to the perforation rate of
gastroscopy?gastroscopy?
– Perforation rate: 0.03%, similar to gastroscopy
– Higher perforation rate in elderly patients (>65y)
and with h/o difficult intubation
![Page 35: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/35.jpg)
Complications of EUS
• What is the infection rate for EUS with FNA?
– Which patients should recieve antibiotic
profilaxis?
![Page 36: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/36.jpg)
Complications of EUS
• What is the infection rate for EUS with FNA?
– Which patients should recieve antibiotic
profilaxis?
– Infection rate: 0.4% - 1.0%; more frequent with
FNA for cystic lesions
– Antibiotic profilaxis for patients with cystic lesions
and after transrectal biopsie
![Page 37: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/37.jpg)
Complications of EUS
• What is the rate of hemorrhagies following
EUS with/without FNA?
![Page 38: Clinical use of endosonography (EUS)](https://reader033.vdocuments.mx/reader033/viewer/2022052405/586b83701a28ab11118c4aac/html5/thumbnails/38.jpg)
Complications of EUS
• What is the rate of hemorrhagies following
EUS with/without FNA?
– Limited hemorrhage: 1.3%